I'm thrilled to inform and personally invite you to a revolutionary, one-of-a-kind event in the European biotechnology sphere which is coming up soon. This event aims at incentivizing the scientific community, all interested stakeholders and the general public in particular about the latest breakthroughs, innovations and trends shaping the future of the biotech industry. The event in question is Taranto Biotech Days which will be taking place from the 11th to the 13th of October in Taranto, Italy. Taranto is a city that has struggled with cleaning up its biosphere from the aftereffects of industrial practices fostered by capitalism which have degraded the environmental quality of the province, leaving its inhabitants with higher cancer and mortality rates compared to the rest of Europe. This event is the first step of a much larger project to build a research foundation in Taranto focused on tackling the city's health issues while simultaneously pioneering techniques and technologies to clean up the ongoing industrial practices which are hazardous to Taranto's ecosystem. At this event, during one of the sessions, I will speak about the research I carried out during my time at UCL on cellular signalling and its importance in the diagnosis of diseases. Over 300 individuals and organizations are already involved in this event with several renowned speakers, researchers, professors and heads of industrial and scientific organizations from all over Europe taking part in the event. The initiative was conceptualized by our small group of scientists and visionaries led by the award-winning Guido Putignano. The main event will take place on the 11th of October with a symposium featuring leaders in industry and academic experts to explore the state of the art in biotechnology and how this can be applied to bettering Taranto's biosphere and the health issues facing some of its people. The following day, there will be a showcase of startups and presentations of grant proposals alongside stakeholders. After this, the rest of the event will be dedicated to exploring the historic landmarks and beautiful sights throughout the city of Taranto with activities such as Dolphin viewing and visits to museums and ancient castles. This event and the project in general promises to be groundbreaking as it aims to improve human life in general, incentivize the scientific community while strengthening efforts of bodies such as the European Union and the United Nations in making our planet safe for all to live in. I look forward to seeing you there as you come with us on this adventure. You can also consider joining us as a partner, supporter or sponsor. Together we can create that ripple effect. Thanks for taking out the time to read this. See you there! PS: Here's the link to the event: https://lnkd.in/dVdvufWM

🌟 Upcoming Panel at SpinOff 2024: "INNAXE: Navigating the European Spin-off Ecosystem" 🌟 Join us for a dynamic discussion exploring the complex landscape of European spin-offs in the Life Sciences and Healthtech sectors. This panel brings together distinguished leaders who are at the forefront of innovation in their respective regions. Event Details: Date: June 21st, 2024 Time: 12:00 - 12:45 Location: Main Stage, SpinOff 2024 Panelists Include: Montse Daban Marín, PhD: As President of the Board at the Council of European BioRegions and Director at BioCat, Montse leverages her vast experience in strategic foresight and international relations to drive forward the bioregion’s agenda, promoting innovative health solutions across Europe. Hickmah Tagaully: Heading European Affairs at Medicen Paris Region, Hickmah focuses on linking biotech and medtech ecosystems across Europe, enhancing collaborative innovations that address complex health challenges. Kristina Eskenazi: Chair of the Health & Life Sciences Cluster, Kristina is instrumental in orchestrating initiatives that propel the Bulgarian life sciences sector onto the global stage, emphasizing sustainable health solutions. Karen Lindegaard: As an International Programme Manager at the Danish Life Science Cluster, Karen facilitates international cooperation, helping Danish life sciences enterprises expand their global footprint through strategic partnerships. Friedemann Loos: Representing the BioRN Life Science Cluster Rhine-Neckar, Friedemann drives the cluster’s efforts in fostering cutting-edge biotechnological research and development, making significant impacts on regional and international biotech landscapes. Alberto Baldi: As a Senior Project Manager at CEBR, Alberto is deeply involved in strengthening Europe's bioregional networks, focusing on enhancing the innovation capacity of clusters through strategic collaborations and knowledge exchange. About INNAXE: INNAXE (Inclusive and Aligned Innovation Agendas Across Europe) is a groundbreaking project led by BioCat under the Horizon Europe framework. This initiative seeks to dynamize and accelerate innovation in Life Sciences and Healthtech by fostering interconnectedness among Europe’s innovation ecosystems. Why Attend? This panel discussion is essential for anyone interested in understanding and navigating the European innovation ecosystem, particularly in the healthtech and life sciences sectors. Insights from these thought leaders will shed light on collaborative efforts and strategies that are shaping the future of healthcare and biotechnological innovations. For registration and more information, please visit www.spinoff.bg. Engage with the minds shaping the future of European innovation at SpinOff 2024! #SpinOff2024 #INNAXE4EU #HealthTech #LifeSciences #EuropeanInnovation

BIONATION 2024 Recap: Showcasing Canada’s Biotech Ecosystem 🌟   Canada’s biotech ecosystem gathered in Ottawa for BIONATION 2024 showcasing the sector's economic and social impact. Over the course of two days; BIONATION united leaders in science, innovation, and entrepreneurship with researchers, investors, policymakers, and the next generation of biotech professionals. The energy and enthusiasm across the ecosystem was undeniable, showcasing not just Canada’s potential, but its shared ambition to build world-class biotech companies on Canadian soil.   The event featured insightful panels on innovation, anchor companies, investment, and talent, along with fireside chats featuring BIOTECanada’s Andrew Casey with the Minister of Health, Hon. Mark Holland, PC, MP, a keynote from astronaut Chris Hadfield, and in a pivotal announcement exclusive to BIONATION 2024, Hon. François-Philippe Champagne, Minister of Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada, announced the creation of the Health Emergency Readiness Canada agency, a crucial step in bolstering the country's pandemic preparedness and enhancing collaboration between healthcare and innovation sectors. This announcement emphasized the need for health and economic policy to work together to fully leverage Canada’s advances in science and innovation.   The Takeaway: Canada has the tools, expertise, and drive to establish anchor companies and a collaborative, ambitious biotech future.   Thank You to our BIOTECanada Members, industry stakeholders, and especially the BIONATION Builders for making this event a success.   For a full recap of BIONATION 2024, and to view our photo gallery, visit: www.biotech.ca/BIONATION #BIONATION #BIONATION2024 #Canada #CdnPoli #innovation #biotech #biotechnology #events #health #lifesciences #investment #membership #ecosystem

🆕 Since 2018 #BioRegionCatalonia has seen steady growth in several innovation indicators, becoming one of the most dynamic and innovative life sciences and healthcare ecosystems in Europe. 🔴 This has led to a some urgent needs such as appropriate workspaces for companies, including labs, production plants and research facilities. ❓ How has the Bioregion of Catalonia tackled these needs? By implementing promising initiatives that will help meet the sector’s current needs and strengthen the ecosystem’s position as a leader in healthcare innovation in Europe and the world. ✔ Some of the new infrastructures inaugurated recently, currently being built or planned for the coming years are: Tech Barcelona, Barcelona Health Hub, Norrsken, BASID, Cosymbio Labs, Hospital Sant Joan de Déu Barcelona, Vall d'Hebron Institute of Oncology (VHIO). IQS Barcelona and Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), CaixaResearch Institute, Vithas, Hospital del Mar, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona Institute for Global Health (ISGlobal), Institut de Recerca Sant Pau, Parc Científic de Barcelona, Innovation and Health Biocluster, Germans Trias i Pujol Research Institute (IGTP) and Girona Campus of Health. 🔎 Curious about the cutting-edge infrastructures driving the future of health innovation? Read about all this science initiatives and hubs in our latest article. https://lnkd.in/dsZRAEUf

The evoleen start-ups DigeHealth and AdHeroes as well as partner companies such as IDUN Technologies are represented at the ETH technology fair. Come and see 👁️ how we transform healthcare! #digitalhealth #healthtech #swisshealthtech

With great pleasure and proud, we share with you a review of 2023: From a Startup to a Company. We had several activities and Talks around the year: OBD presented the objective as part of the companies portfolio founded by Gridx in the Latin America and the Caribbean High level conference. An exhibition of Latin American Innovation and Patents. Presentation by Judith Zavala Arcos, PhD. Presenting a pitch to VOX Group Capital from Brazil to get to know our technology. Participation in Boston, BIO INTERNATIONAL CONVENTION by María Dolores Montalvo, PhD. Also a participation in SoCalBio Bootcamp for Emerging Companies. BIO INTERNATIONAL CONVENTION By María Dolores Montalvo, PhD. as well as María Judith Zavala, PdD. Among other activities, Judith Zavala Arcos, PhD was part of the women invited to the 10 years celebration of La French Tech México event. Participation in INC Monterrey (https://lnkd.in/eQhUq-jV), the event of Entrepreneurship, Innovation, Business and Sustainability in Latin America, FUTURE NOW, Jorge Valdez, M.D., talk about Entrepreneurs. And in BIotech Company Building with Gridx. In the 2023 AAHCI Latin America and the Caribbean Regional Meeting we participate as speakers in the panel. Besides all these activities, we were working in Preclinical Tests that help us to predict how the Synthetic Tissue works. And we are getting there! Wrote different articles: Advanced Therapies in Ophtalmology https://lnkd.in/gMrDgap4 The Challenge of Funding a Cornea lab, that can change the blindness fight. https://lnkd.in/gFPunKEG. In the Magazine LEADERS, The Best Physicians in Mexico, Jorge E. Valdez García, M.D., PhD was mention among them. We also were mention in different media communications: La Jornada, Interview to. Jorge E. Valdez, M.D., PhD. https://lnkd.in/gMrDgap4. Interview in Reporte Salud to Jorge E. Valdez, M.D., PhD and Judith Zavala, PhD. https://lnkd.in/g2MRPxfp. FORBES, La Crónica, Contraréplica, Red Financiera, Enlace Informativo, Pasión Móvil among others. WHAT DO WE HAVE FOR 2024? Scientific Advances Participation in ARVO (Association for Research in Vision and Ophtalmology in Seattle, U.S.A.) And more activities along the year. Follow us for more information. Jorge E. Valdez-García Judith Zavala Arcos Maria M. GRIDX #CornealTissue #Cornea #OcularBioDesign

🚀 Day 7: Understanding the Core Customer and Value Proposition with Michio Painter, PhD from the UMZH Translational Medicine Accelerator (TMA)! 💡 Tomorrow, our BEI teams will focus on presenting: 1️⃣ Who is the core customer of their future product? 2️⃣ What huge problem does this customer face? 3️⃣ What is the #1 value proposition their solution offers? 💡 About the UMZH Translational Medicine Accelerator (TMA)💡 The TMA supports researchers & entrepreneurs to critically evaluate their translational ideas, sharpen those ideas towards a viable commercial product, and ultimately advance that product through a spinout or other partnerships. We are open to all lifescience researchers under UMZH which includes University of Zurich, ETH Zürich, and all affiliated hospitals.  🧬 Let's keep pushing innovation forward! 🔥 #healthcareinnovation #valueproposition #lifesciences #entrepreneurship #BEIprogram #UZH #ETH #USZ #biotech #medtech #digitalhealth

Embrace collaboration with those around you at every opportunity, even if it's just for a brief moment. Make each interaction count, because in the grand scheme, the world is your team ! This is not a Ghandi’s quote but just what these 3 days at BIO Europe Spring inspired me 😊. Having met with people from Barcelona, Japan, Korea, the UK, the US, from the Nordics and from all Europe developing cutting-edge solutions in AI-driven drug discovery, in-vitro research biotools, real world data access, bioinformatics, modalities-of-the-future contract research and manufacturing, venture capital and lab-as-a-service. This was a strong accelerator for BVI.EU’s TechBio science park Quantum Biospace, promoting awareness about the premium mixed-use 70.000sqm real estate offering developed in Wavre North, Walloon Brabant at the crossroad of Belgium’s three BioRegions, including dry labs, wet labs, biocontainment labs, clean rooms, manufacturing facilities and offices. BIO EUROPE Spring was also a unique booster for Quantum BioVenture Studio, the AI-driven drug discovery start-up factory, beating heart of Quantum Biospace. Stay tuned to discover the key milestones we will be announcing in the coming weeks about the studio. 🌍Visit our brand-new website and be part of Belgium’s TechBio revolution: www.quantumbiospace.ai Wallonia.be/en Wallonia Export & Investment Agency BioWin - The Health Cluster of Wallonia Mehdy Oozeer DANTINNE MARIE ANNE Alexandra Schiettekatte Geoffroy Dumonceau de Bergendal Michel Meers Jurgen Mesens #bioeuropespring

LIFE SCIENCE UMEÅ BOOSTED BY TWO EU PROJECTS. 🎯Life Science Umeå is really making strides. In addition to the municipality's new establishment strategy, the cutting-edge research at the university, and the flourishing industry, two ongoing regional development projects aim to boost innovation, collaboration, and industry growth. 💰The projects receive around €1.8 million (22 million SEK) in EU support. ✨Umeå Biotech Incubator runs ”Life Science City” to further propel Umeå’s life science industry and foster innovation and collaboration. 🤝The SOLH (Support Office Life science and Health) project is a collaborative effort between Umeå universitet, Region Västerbotten, Region Norrbotten, Luleå tekniska universitet, Umeå University Holding, and the municipalities, Skellefteå kommun and Umeå kommun. ✅SOLH addresses the need for a more streamlined and unified innovation system within life sciences across northern Sweden. 📣“It’s exciting to see the investment in two new life science development projects in Umeå and the surrounding region. When you factor in co-financing, the total amount is more than doubled. This commitment will fuel progress on all fronts,” says Peter Jacobsson, Operations Coordinator at UBI. 📣“We already possess a well-established collaborative foundation, and with these two projects combined, we, and hopefully the entire industry, will emerge even stronger,” states Mats Falck, project leader for SOLH. #umeåmerlifescience #lifescience https://lnkd.in/gKtZEG9h

🌟 Exploring synergies 🧬 Last Monday, within the scope of the project Iberos+ (Interreg-POCTEP), researchers from the i3S - Instituto de Investigação e Inovação em Saúde visited the Escola Superior de Biotecnologia da Universidade Católica Portuguesa. 🔬 Members from both the i3S - Instituto de Investigação e Inovação em Saúde team and the UCP Biomaterials and Biomedical Technology group showcased their ongoing research efforts, fostering collaboration and partnership opportunities. 💡 Working together for biotech progress! #ResearchCollaboration